Related by context. Frequent words. (Click for all words.) 73 prospective randomized 72 randomized clinical 72 randomized placebo controlled 71 multicenter 71 phase IIb 71 multicenter randomized double 71 Phase 2a clinical 70 randomized controlled 70 randomized Phase 70 Phase IIb clinical 70 blind randomized placebo 70 Phase Ib 69 placebo controlled 69 Phase 2b clinical 69 Phase 2a trial 67 Phase 2b study 67 Phase 1b 67 randomized double 67 Phase 2b 67 dose escalation study 67 Phase IIa clinical 66 Phase IIb trial 66 Phase IIa trial 66 blind randomized 66 mCRC 66 randomized 65 Phase III clinical 65 label dose escalation 65 Phase 2a 65 pivotal Phase III 65 Phase 2b trial 65 Phase III 65 sunitinib 65 Phase IIa 64 multicenter study 64 dose escalation 64 Phase III pivotal 64 Phase IIb 63 double blind placebo 63 multiple ascending dose 63 single ascending dose 63 vandetanib 63 pivotal Phase 62 ACTEMRA 62 sorafenib 62 HGS ETR1 62 randomized trials 62 pemetrexed 61 FOLFOX 61 randomized clinical trials 61 IMGN# 61 clinical trial 61 pharmacodynamics 61 gemcitabine 61 hepatocellular carcinoma HCC 61 Taxotere R 60 metastatic colorectal cancer 60 placebo controlled trials 60 randomized controlled trial 60 evaluable patients 60 ofatumumab 60 docetaxel 60 DSMB 60 randomized #:# 59 non inferiority 59 CYT# 59 unblinded 59 denufosol 59 ticagrelor 59 advanced NSCLC 59 eculizumab 59 confirmatory Phase 3 59 AP# [003] 59 antitumor activity 59 gefitinib 59 bevacizumab 59 ThermoDox 59 Phase III trials 59 MLN# 59 FOLOTYN 59 blinatumomab 59 ASA# 58 T DM1 58 Clolar 58 free survival PFS 58 Randomized 58 Actemra 58 carboplatin 58 tolerability 58 ZYBRESTAT 58 blind placebo controlled 58 Alpharadin 58 dasatinib 58 RG# [001] 58 resistant ovarian cancer 58 VELCADE 58 pegylated interferon 58 cutaneous T cell 58 CYPHER R Stent 58 monotherapy 58 lupus nephritis